The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection

Published:2020-12-17 Issue:4 Volume:22 Page:254-261
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Figueroa MI¹,Camiro‐Zuñiga A²^ORCID,Belaunzaran‐Zamudio PF³,Sierra Madero J³,Andrade Villanueva J⁴,Arribas JR⁵,Lama JR⁶,Cecchini DM⁷^ORCID,Lopardo G⁸,Crabtree‐Ramírez B³,Gun A¹,Patterson P¹,Fink VI¹,Sued OG¹^ORCID,Cahn P¹

Affiliation:

1. Fundación Huésped Buenos Aires Argentina

2. Centro Médico ABC Mexico City Mexico

3. Departamento de Infectología Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico

4. Hospital Civil Fray Antonio Alcalde Guadalajara Mexico

5. La Paz University Hospital Madrid Spain

6. Asociación Civil Impacta Salud y Educación Lima Perú

7. Hospital Argerich Buenos Aires Argentina

8. Centro de Estudios Infectológicos Buenos Aires Argentina

Funder

AbbVie Biotherapeutics

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13008

Reference23 articles.

1. Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients

2. New Strategies of ARV: the Road to Simplification

3. Darunavir-based dual therapy of treatment-experienced HIV-infected patients: analysis from a national multicenter database

4. Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

5. Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD4/CD8 Ratio During Human Immunodeficiency Virus Treatment: Time for Routine Monitoring?;Clinical Infectious Diseases;2023-03-08

2. Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV;Frontiers in Immunology;2022-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3